New combo therapy aims to boost liver cancer surgery success
Disease control
Recruiting now
This study is testing a combination of two drugs (apatinib and camrelizumab) plus a procedure called TACE as a treatment given before surgery for liver cancer. The goal is to shrink the tumor first, making it easier to remove completely during surgery and hopefully lowering the c…
Phase: PHASE2 • Sponsor: Wei Zhang • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC